Малена Коэн-Кимберкно

Научные публикации

• Long-term therapy with CFTR modulators consistently improves glucose metabolism in adolescents and adults with cystic fibrosis
• Maternal and fetal outcomes in multiparous women with Cystic Fibrosis
• Clinical efficacy of CFTR modulator therapy in people with cystic fibrosis carrying the I1234V mutation
• Optimizing CFTR modulator therapy management for cystic fibrosis through the ReX platform
• Changes in Sleep in Children and Adults with Cystic Fibrosis and Primary Ciliary Dyskinesia over Time and after CFTR Modulator Therapy
• The new face of cystic fibrosis in the era of population genetic carrier screening
• Ovarian reserve in women with cystic fibrosis: is this a cause of sub-fertility?
• Clinical and functional efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis carrying the N1303K mutation
• Eradication of Nontuberculous Mycobacteria in People with Cystic Fibrosis Treated with Elexacaftor/Tezacaftor/Ivacaftor: A Multicenter Cohort Study
• Pediatric respiratory admissions and related viral infections during the COVID-19 pandemic
• The association between Attention-Deficit-Hyperactivity-Disorder (ADHD) symptoms and disease severity in people with Cystic Fibrosis (pwCF)
• Acute pancreatitis in pancreatic-insufficient cystic fibrosis patients treated with CFTR modulators
• The Impact of Highly Effective Cystic Fibrosis Transmembrane Conductance Regulator Modulators on the Health of Female Subjects With Cystic Fibrosis
• Treatment effects of Elexacaftor/Tezacaftor/Ivacaftor in people with CF carrying non-F508del mutations
• The clinical yield of bronchoscopy in the management of cystic fibrosis: A retrospective multicenter study
• The utility of glucose area under the curve from the oral glucose tolerance test as a screening tool for cystic fibrosis-related diabetes
• Targeting Persistent Biofilm Infections: Reconsidering the Topography of the Infection Site during Model Selection
• Calcium carbonate mineralization is essential for biofilm formation and lung colonization
• Respiratory physiotherapy in patients with cystic fibrosis and upper limb deep vein thrombosis
• Lung function from school age to adulthood in primary ciliary dyskinesia
• Antisense oligonucleotide splicing modulation as a novel Cystic Fibrosis therapeutic approach for the W1282X nonsense mutation
• Expanding clinical phage microbiology: simulating phage inhalation for respiratory tract infections
• Manual external chest compression reverses respiratory failure in children with severe air trapping
• Ethical Dilemma: Elexacaftor-Tezacaftor-Ivacaftor or Lung Transplantation in Cystic Fibrosis and End-Stage Lung Disease?
• Fertility and Pregnancy in Cystic Fibrosis
• The Use of Infant Pulmonary Function Tests in the Diagnosis of Neuroendocrine Cell Hyperplasia of Infancy
• Sleep in children with cystic fibrosis: More under the covers
• Regional differences in pediatric asthma hospital admissions: National data from Israel 1996-2017
• Lymphadenopathy Associated With the COVID-19 Vaccine
• A Green Light for Stop Mutations
• How abnormal is the normal? Clinical characteristics of CF patients with normal FEV₁
• Betamethasone versus dexamethasone for inpatient preschool wheezing-A case-control study
• Whole-exome sequencing accuracy in the diagnosis of primary ciliary dyskinesia
• Ivacaftor in People with Cystic Fibrosis and a 3849+10kb C→T or D1152H Residual Function Mutation
• Baseline Cystic fibrosis disease severity has an adverse impact on pregnancy and infant outcomes, but does not impact disease progression
• Phenotypic and molecular characteristics of CF patients carrying the I1234V mutation
• Cystic fibrosis in low and middle-income countries (LMIC): A view from four different regions of the world
• The Long-Term Effect of a Quality Improvement Intervention in the Management of Bronchiolitis
• Hydrocarbon Intoxication in Children: Clinical and Sociodemographic Characteristics
• Sleep disorders in cystic fibrosis: A systematic review and meta-analysis
• Sleep disorders in patients with primary ciliary dyskinesia, cystic fibrosis with and without pancreatic insufficiency
• Giant lung cysts following necrotizing pneumonia: Resolution with conservative treatment
• Failure to conceive in women with CF is associated with pancreatic insufficiency and advancing age
• Increasing Vitamin D Serum Levels Is Associated With Reduced Pulmonary Exacerbations in Patients With Cystic Fibrosis
• Primary sclerosing cholangitis is associated with abnormalities in CFTR
• A quality improvement intervention to reduce emergency department radiography for bronchiolitis
• Attention deficit hyperactivity disorder symptoms in patients with cystic fibrosis
• Clinical impact of Pseudomonas aeruginosa colonization in patients with Primary Ciliary Dyskinesia
• Ivacaftor for the p.Ser549Arg (S549R) gating mutation - The Israeli experience
• Predictors of Prolonged Hospitalizations in Pediatric Complicated Pneumonia
• Nationwide genetic analysis for molecularly unresolved cystic fibrosis patients in a multiethnic society: implications for preconception carrier screening
• Autosomal dominant gain of function STAT1 mutation and severe bronchiectasis
• Collecting clinical data in primary ciliary dyskinesia- challenges and opportunities
• Primary ciliary dyskinesia in Israel: Prevalence, clinical features, current diagnosis and management practices
• Comparison of Nasal Potential Difference and Intestinal Current Measurements as Surrogate Markers for CFTR Function
• Complicated community acquired pneumonia in childhood: Different types, clinical course, and outcome
• Eradication failure of newly acquired Pseudomonas aeruginosa isolates in cystic fibrosis
• Treatment of cystic fibrosis in low-income countries
• Hepatopulmonary Syndrome in Patients With Cystic Fibrosis and Liver Disease
• Disparities in Cystic Fibrosis Care and Outcome: Socioeconomic Status and Beyond
• Ataluren for the treatment of cystic fibrosis
• Reversible airway obstruction in cystic fibrosis: Common, but not associated with characteristics of asthma
• Systematic Analysis of CCNO Variants in a Defined Population: Implications for Clinical Phenotype and Differential Diagnosis
• Adherence pattern to study drugs in clinical trials by patients with cystic fibrosis
• The impact of a national population carrier screening program on cystic fibrosis birth rate and age at diagnosis: Implications for newborn screening
• Association of chronic Candida albicans respiratory infection with a more severe lung disease in patients with cystic fibrosis
• A reach-out system for video microscopy analysis of ciliary motions aiding PCD diagnosis
• Antibiotic treatment for children hospitalized with community-acquired pneumonia after oral therapy
• Long-term follow-up of distal intestinal obstruction syndrome in cystic fibrosis
• Continuous intravenous β-lactam antibiotics in cystic fibrosis patients with severe drug hypersensitivity
• Differences in disease expression between primary ciliary dyskinesia and cystic fibrosis with and without pancreatic insufficiency
• CCDC65 mutation causes primary ciliary dyskinesia with normal ultrastructure and hyperkinetic cilia
• Airway inflammation in cystic fibrosis: molecular mechanisms and clinical implications
• Mitochondrial OXPHOS function is unaffected by chronic azithromycin treatment
• LRRC6 mutation causes primary ciliary dyskinesia with dynein arm defects
• Differences in the pattern of structural abnormalities on CT scan in patients with cystic fibrosis and pancreatic sufficiency or insufficiency
• Evaluation of the intestinal current measurement method as a diagnostic test for cystic fibrosis
• Antibiotic treatment of children with community-acquired pneumonia: comparison of penicillin or ampicillin versus cefuroxime
• Concomitant cystic fibrosis and coeliac disease: reminder of an important clinical lesson
• Could you please pass the salt?
• Managing cystic fibrosis: strategies that increase life expectancy and improve quality of life
• Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis
• Late-onset central hypoventilation presenting as extubation failure
• 18F-fluorodeoxyglucose-PET/CT imaging of lungs in patients with cystic fibrosis
• Meconium ileus in patients with cystic fibrosis is not a risk factor for clinical deterioration and survival: the Israeli Multicenter Study
• Intravenous monthly pulse methylprednisolone treatment for ABPA in patients with cystic fibrosis
• Primary ciliary dyskinesia: prospects for new therapies, building on the experience in cystic fibrosis